Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07407153Not ApplicableRecruiting

Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device

Role: collaborator

NCT07252843Completed

Integrating Clinical, Protein Expression, and Genetic Markers to Predict Lymphedema in Breast Cancer

Role: lead

NCT07233863Not ApplicableRecruiting

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Role: lead

NCT06942286Not ApplicableEnrolling By Invitation

Primary HPV Self-Collection in Indonesia

Role: lead

NCT07144475Phase 4Completed

Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery

Role: lead

NCT06993740Not ApplicableRecruiting

Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

Role: lead

NCT05682885Not ApplicableActive Not Recruiting

The Effectiveness of Lymphatic Bypass Supermicrosurgery

Role: lead

NCT04864431Not ApplicableUnknown

Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer

Role: collaborator

NCT02995772Phase 3Completed

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Role: lead

NCT03504631Unknown

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Role: collaborator

All 10 trials loaded